Clinical trial for evaluation of effect of procalcitonin-based algorithm in duration of antibiotic therapy and hospitalization of community acquired pneumonia and chronic obstructive pulmonary disease exacerbation

Arak University of Medical Sciences0 个研究点目标入组 140 人开始时间: 待定最近更新: 2018年2月22日

试验速览

暂无简介。

•Patients to be at least 18 years; with diagnosis of Community Acquired Pneumonia ( CAP ) or Chronic Obstructive Pulmonary Disease ( COPD ) exacerbation; with at least one respiratory symptom ( cough, sputum, dyspnea, tachypnea, pleuretic chest pain ); in addition to at least one respiratory sign on auscultation (rales,cripitation); or one infection indicator ( T greater than 38 c, chills, WBC less than 4000 or greater than 10000 per milliliter ); hospitalized in Infectious ward of Arak Valiasr University Hospital.
•Exclusion criteria:
•Patients that can't consent voluntary; active IV drug users; severe immunosuppression ( except use of corticosteroid ); severe comorbidity; patients with hospital- acquired pneumonia ( pneumonia presented at 48 hours after hospitalization or previous history of hospitalization during 14 days before this admission ); patients requiring antibiotic therapy for chronic infection.

发起方